# AnHeart Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anheart-therapeutics

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.anhearttherapeutics.com/
- Total disclosed funding: $76M
- Latest round: Series B (Dec 14, 2021)
- Investors on record: 7

## About

Founded in 2018, and based in New York, US, AnHeart Therapeutics Inc. is a multinational clinical-stage biopharmaceutical business that creates treatments for cancer patients. The company was founded by its CEO, Junyuan Jerry Wang, and President Bing Yan. In April 2024, Nuvation Bio, Inc. acquired AnHeart Therapeutics (Hangzhou) Co., Ltd. from Decheng Capital, China Merchants Capital, Cenova Ventures, and Innovent Biologics, Inc. Following the acquisition, AnHeart Therapeutics shareholders own 33%, and the stockholders of Nuvation Bio own 67% of Nuvation Bio on a fully diluted basis.

AnHeart Therapeutics develops, creates, and commercializes biotechnology-based novel oncology medicines and treatments for patients suffering from cancer. As of 2024, the company’s product pipeline includes clinical-stage therapeutic cancer treatments such as taletrectinib (a ROS1 inhibitor) and safusidenib (a mIDH1 inhibitor). The treatments significantly enhance patient health by focusing on and attacking vital pathways in cancer cells.

## Funding rounds

- Series B, Dec 14, 2021, $61M — Cenova Ventures, Laurion Capital Management, Innovent Biologics, Inc., Sage Partners, Octagon Capital Investments
- Series A, Aug 7, 2020 — China Merchants Capital
- Series A, May 17, 2019, $15M — Decheng Capital

## Investors

- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series A
- China Merchants Capital (https://capitalatlas.ai/funds/china-merchants-capital) — Series A
- Cenova Ventures (https://capitalatlas.ai/funds/cenova-ventures) — Series B
- Laurion Capital Management — Series B
- Innovent Biologics, Inc. — Series B
- Sage Partners (https://capitalatlas.ai/funds/sage-partners) — Series B
- Octagon Capital Investments (https://capitalatlas.ai/funds/octagon-capital-investments) — Series B